Intact Investment Management Inc. Sells 65,100 Shares of Colgate-Palmolive Company $CL

Key Points

• Intact Investment Management cut its stake in Colgate‑Palmolive by 72.7% in Q4, selling 65,100 shares and leaving 24,400 shares worth about $1.93 million.
• Company insiders sold heavily over the past three months—totaling 184,683 shares valued at roughly $17.49M—including COO Panagiotis Tsourapas (15,000 shares at $97.81) and John Hazlin (20,989 shares at $94.25), leaving insiders with 0.43% ownership.
• Colgate beat quarterly estimates with EPS $0.97 vs $0.94 and revenue of $5.32B, raised its quarterly dividend to $0.53 (annualized $2.12, yield 2.5%), and carries a consensus "Moderate Buy" rating with an average target of $95.81.

Intact Investment Management Inc. lowered its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 72.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,400 shares of the company's stock after selling 65,100 shares during the period. Intact Investment Management Inc.'s holdings in Colgate-Palmolive were worth $1,928,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in CL. Sunpointe LLC increased its holdings in Colgate-Palmolive by 4.0% during the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company's stock valued at $241,000 after buying an additional 117 shares during the period. Capital Advisors Inc. OK lifted its holdings in Colgate-Palmolive by 1.4% during the fourth quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company's stock worth $758,000 after buying an additional 129 shares during the period. Stratos Wealth Advisors LLC lifted its holdings in Colgate-Palmolive by 4.5% during the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company's stock worth $241,000 after buying an additional 130 shares during the period. Eads & Heald Wealth Management lifted its holdings in Colgate-Palmolive by 0.6% during the fourth quarter. Eads & Heald Wealth Management now owns 20,744 shares of the company's stock worth $1,639,000 after buying an additional 132 shares during the period. Finally, Chicago Partners Investment Group LLC grew its holdings in Colgate-Palmolive by 1.5% in the third quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company's stock worth $724,000 after purchasing an additional 136 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Insider Activity at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the business's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares of the company's stock, valued at $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the business's stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 184,683 shares of company stock valued at $17,486,693 over the last three months. 0.43% of the stock is owned by corporate insiders.

Colgate-Palmolive Price Performance

Shares of CL opened at $85.28 on Tuesday. The firm has a market capitalization of $68.42 billion, a PE ratio of 33.18, a price-to-earnings-growth ratio of 4.46 and a beta of 0.31. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.44 and a quick ratio of 0.29. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company's fifty day moving average price is $87.95 and its 200-day moving average price is $84.15.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.94 by $0.03. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 earnings per share. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.85 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. Colgate-Palmolive's dividend payout ratio is presently 82.49%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CL. Bank of America cut their price target on shares of Colgate-Palmolive from $105.00 to $102.00 and set a "buy" rating on the stock in a report on Friday, April 10th. Citigroup lifted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a "buy" rating in a report on Monday, February 2nd. The Goldman Sachs Group reaffirmed a "buy" rating on shares of Colgate-Palmolive in a report on Friday. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of Colgate-Palmolive in a report on Monday. Twelve equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $95.81.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.